Avalon GloboCare Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 8
Employees
  • Stock Symbol
  • AVCO
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $1.14
  • (As of Thursday Closing)

Avalon GloboCare General Information

Description

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has two reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States
+1 (732) 000-0000

Avalon GloboCare Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avalon GloboCare Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.14 $1.21 $0.50 - $2.19 $98.5M 81.4M 380K -$0.19

Avalon GloboCare Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 102,302 144,242 197,289 169,790
Revenue 1,402 1,546 1,562 1,078
EBITDA (13,913) (17,481) (7,215) (3,731)
Net Income (15,028) (18,070) (7,774) (3,464)
Total Assets 11,156 10,491 13,396 12,669
Total Debt 3,450 3,190 1,000 1,500
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avalon GloboCare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avalon GloboCare‘s full profile, request access.

Request a free trial

Avalon GloboCare Executive Team (5)

Name Title Board Seat Contact Info
David Jin Ph.D Chief Executive Officer & Board Member
Luisa Ingargiola Chief Financial Officer
Meng Li Chief Operating Officer, Operations & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

Avalon GloboCare Board Members (5)

Name Representing Role Since
00000 000 00.0 Avalon GloboCare Chief Executive Officer & Board Member 000 0000
0000 00 Avalon GloboCare Chief Operating Officer, Operations & Board Member 000 0000
000000 0000000 00 Self Board Member 000 0000
0000000 000000 Avalon GloboCare Board Member 000 0000
0000000 0000000 000 Self Board Member 000 0000
To view Avalon GloboCare’s complete board members history, request access »

Avalon GloboCare Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avalon GloboCare Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 23-Oct-2018 00000 0000000 Drug Discovery 00000 000 00.0
000000 0000000 01-Sep-2018 00000 0000000 Biotechnology 00000 000 00.0
0000000000 0000000 31-Oct-2017 000000000000000000 00.000 Application Software 00000 000 00.0
0000000 0000000 (0 25-Oct-2017 000000000000000000 00000 Drug Discovery 00000 000 00.0
Freehold Executive Center 05-May-2017 Corporate Asset Purchase 00.000 Buildings and Property 00000 000 00.0
To view Avalon GloboCare’s complete investments and acquisitions history, request access »